T1	PROC 44 99	ENSAYO CLÍNICO DE FASE II, ABIERTO, UNICÉNTRICO, PILOTO
T2	PROC 105 176	EVALUAR LAS CARACTERÍSTICAS FARMACOCINÉTICAS, SEGURIDAD Y TOLERABILIDAD
T3	CHEM 211 225	INMUNOSUPRESOR
#1	AnnotatorNotes T3	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T4	CHEM 230 238	ADVAGRAF
#2	AnnotatorNotes T4	C4082808; Advagraf; Organic Chemical · Pharmacologic Substance
T5	PROC 269 288	TRASPLANTE PULMONAR
#3	AnnotatorNotes T5	C0024128; Lung Transplantation; Therapeutic or Preventive Procedure
T6	PROC 320 340	Transplante pulmonar
#4	AnnotatorNotes T6	C0024128; Lung Transplantation; Therapeutic or Preventive Procedure
T7	ANAT 332 340	pulmonar
#5	AnnotatorNotes T7	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T8	PROC 476 497	pauta inmunosupresora
T9	CHEM 482 497	inmunosupresora
#6	AnnotatorNotes T9	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T10	CHEM 508 516	Advagraf
#7	AnnotatorNotes T10	C4082808; Advagraf; Organic Chemical · Pharmacologic Substance
T11	PROC 545 573	continuar con el tratamiento
#8	AnnotatorNotes T11	C2091305; continue current medication; Therapeutic or Preventive Procedure
T12	CHEM 669 679	tacrolimus
#9	AnnotatorNotes T12	C0085149; tacrolimus; Organic Chemical · Pharmacologic Substance
T13	ANAT 683 689	sangre
#10	AnnotatorNotes T13	C0005767; Blood; Body Substance
T14	PROC 933 969	consentimiento informado por escrito
#11	AnnotatorNotes T14	C0811741; Obtain informed written consent; Health Care Activity
T15	PROC 1165 1172	tratado
#12	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T16	DISO 1043 1052	neoplasia
#13	AnnotatorNotes T16	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C1882062; Neoplastic disease; Neoplastic Process
T17	DISO 1071 1080	neoplasia
#14	AnnotatorNotes T17	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C1882062; Neoplastic disease; Neoplastic Process
T18	DISO 1114 1164	carcinoma basocelular o epidermoide no metastásico
T19	PROC 1205 1219	diagnosticados
#15	AnnotatorNotes T19	C0011900; Diagnosis; Diagnostic Procedure
T20	DISO 1223 1240	fibrosis quística
#16	AnnotatorNotes T20	C0010674; Cystic Fibrosis; Disease or Syndrome
T21	DISO 1258 1280	infección generalizada
#17	AnnotatorNotes T21	C0243026; Sepsis; Disease or Syndrome
T22	PROC 1295 1306	tratamiento
#18	AnnotatorNotes T22	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T23	DISO 1324 1331	diarrea
#19	AnnotatorNotes T23	C0011991; Diarrhea; Sign or Symptom
T24	DISO 1340 1347	vómitos
#20	AnnotatorNotes T24	C0042963; Vomiting; Sign or Symptom
T25	DISO 1349 1363	úlcera péptica
#21	AnnotatorNotes T25	C0030920; Peptic Ulcer; Disease or Syndrome
T26	DISO 1745 1774	función pulmonar no aceptable
T27	DISO 1374 1395	trastornos digestivos
T28	ANAT 1385 1395	digestivos
#22	AnnotatorNotes T28	C0012240; Gastrointestinal system; Body System
T29	CHEM 1431 1441	tacrolimus
#23	AnnotatorNotes T29	C0085149; tacrolimus; Organic Chemical · Pharmacologic Substance
T30	CHEM 1518 1526	Envarsus
#24	AnnotatorNotes T30	C4050793; Envarsus; Organic Chemical · Pharmacologic Substance
T31	CHEM 1506 1514	Advagraf
#25	AnnotatorNotes T31	C4082808; Advagraf; Organic Chemical · Pharmacologic Substance
T32	DISO 1580 1593	rechazo agudo
#26	AnnotatorNotes T32	C0548926; Acute rejection of transplanted organ; Pathologic Function | C3273245; Acute Rejection; Finding
T33	DISO 1638 1653	Rechazo crónico
#27	AnnotatorNotes T33	C0301948; Chronic graft rejection; Pathologic Function
T34	PROC 1654 1667	diagnosticado
#28	AnnotatorNotes T34	C0011900; Diagnosis; Diagnostic Procedure
T35	DISO 1671 1688	Cirrosis hepática
#29	AnnotatorNotes T35	C0023890; Liver Cirrhosis; Disease or Syndrome
T36	ANAT 1753 1761	pulmonar
#30	AnnotatorNotes T36	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T37	PROC 1779 1782	GPT
#31	AnnotatorNotes T37	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T38	PROC 1802 1819	bilirrubina total
#32	AnnotatorNotes T38	C0201913; Bilirubin, total measurement; Laboratory Procedure
T39	CHEM 1830 1840	Creatinina
#33	AnnotatorNotes T39	C0010294; creatinine; Biologically Active Substance · Organic Chemical
T40	ANAT 1841 1847	sérica
#34	AnnotatorNotes T40	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T41	DISO 1881 1892	toxicomanía
#35	AnnotatorNotes T41	C1510472; Drug Dependence; Mental or Behavioral Dysfunction
T42	DISO 1894 1916	trastorno psiquiátrico
#36	AnnotatorNotes T42	C0004936; Mental disorders; Mental or Behavioral Dysfunction
T43	DISO 1919 1927	afección
#37	AnnotatorNotes T43	C0221423; Illness (finding); Sign or Symptom
T44	PROC 2071 2095	estudio de investigación
#38	AnnotatorNotes T44	C0681814; research study; Research Activity
T45	DISO 2160 2173	VIH positivos
#39	AnnotatorNotes T45	C4759637; HIV positive status; Finding
T46	PROC 2216 2239	métodos anticonceptivos
#40	AnnotatorNotes T46	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T47	PROC 2288 2312	consentimiento informado
#41	AnnotatorNotes T47	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T48	PROC 203 225	RÉGIMEN INMUNOSUPRESOR
T49	CHEM 242 250	ENVARSUS
#42	AnnotatorNotes T49	C4050793; Envarsus; Organic Chemical · Pharmacologic Substance
T50	ANAT 280 288	PULMONAR
#43	AnnotatorNotes T50	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T51	PROC 669 689	tacrolimus en sangre
#44	AnnotatorNotes T51	C1271702; Blood tacrolimus level; Laboratory Procedure
T52	ANAT 1124 1135	basocelular
#45	AnnotatorNotes T52	C0596155; Basal Cell; Cell
T53	PROC 1490 1501	tratamiento
#46	AnnotatorNotes T53	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T54	ANAT 1680 1688	hepática
#47	AnnotatorNotes T54	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T55	PROC 1784 1787	ALT
#48	AnnotatorNotes T55	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T56	PROC 1790 1793	GOT
#49	AnnotatorNotes T56	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T57	PROC 1795 1798	AST
#50	AnnotatorNotes T57	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T58	CHEM 1802 1813	bilirrubina
#51	AnnotatorNotes T58	C0005437; Bilirubin; Biologically Active Substance · Organic Chemical
T59	PROC 1830 1847	Creatinina sérica
#52	AnnotatorNotes T59	C0201976; Creatinine measurement, serum (procedure); Laboratory Procedure
T60	Date 12 16	2015
T61	PHYS 133 149	FARMACOCINÉTICAS
#53	AnnotatorNotes T61	C0031327; Drug Kinetics; Physiologic Function
T62	LIVB 255 264	PACIENTES
#54	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T63	LIVB 377 386	Pacientes
#55	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T64	Age 411 429	entre 18 y 65 años
T65	LIVB 450 459	Pacientes
#56	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T67	Duration 574 596	un mínimo de 4 semanas
T68	LIVB 600 609	Pacientes
#57	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T72	Duration 770 785	al menos 6 días
T73	LIVB 821 830	Pacientes
#58	AnnotatorNotes T73	C0030705; Patients; Patient or Disabled Group
T74	LIVB 1029 1038	Pacientes
#59	AnnotatorNotes T74	C0030705; Patients; Patient or Disabled Group
T75	Duration 1084 1105	los 5 años anteriores
T76	Neg_cue 1106 1113	excepto
T78	LIVB 1195 1204	Pacientes
#60	AnnotatorNotes T78	C0030705; Patients; Patient or Disabled Group
T79	LIVB 1244 1253	Pacientes
#61	AnnotatorNotes T79	C0030705; Patients; Patient or Disabled Group
T80	LIVB 1310 1319	Pacientes
#62	AnnotatorNotes T80	C0030705; Patients; Patient or Disabled Group
T82	LIVB 1446 1455	Pacientes
#63	AnnotatorNotes T82	C0030705; Patients; Patient or Disabled Group
T83	Duration 1597 1611	los tres meses
T84	Duration 1646 1653	crónico
#64	AnnotatorNotes T84	C0205191; chronic; Temporal Concept
T85	LIVB 1717 1726	Pacientes
#65	AnnotatorNotes T85	C0030705; Patients; Patient or Disabled Group
T88	LIVB 1860 1869	Pacientes
#66	AnnotatorNotes T88	C0030705; Patients; Patient or Disabled Group
T89	LIVB 1954 1966	investigador
#67	AnnotatorNotes T89	C0035173; Research Personnel; Professional or Occupational Group
T91	LIVB 2004 2013	Pacientes
#68	AnnotatorNotes T91	C0030705; Patients; Patient or Disabled Group
T92	Duration 2099 2110	los 28 días
T93	LIVB 2150 2159	Pacientes
#69	AnnotatorNotes T93	C0030705; Patients; Patient or Disabled Group
T94	LIVB 2177 2199	Mujeres en edad fértil
#70	AnnotatorNotes T94	C4324275; Woman of childbearing potential; Population Group
T95	Neg_cue 2204 2206	no
T96	PHYS 2251 2259	Embarazo
#71	AnnotatorNotes T96	C0032961; Pregnancy; Organism Function
T97	PHYS 2262 2271	lactancia
#72	AnnotatorNotes T97	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T98	Neg_cue 2275 2277	No
T69	PHYS 1418 1427	absorción
#73	AnnotatorNotes T69	C0678745; drug absorption; Physiologic Function
T70	PHYS 1745 1761	función pulmonar
#74	AnnotatorNotes T70	C0035245; Respiratory physiology; Physiologic Function
T77	Age 2188 2199	edad fértil
T66	PHYS 842 850	entender
#75	AnnotatorNotes T66	C0162340; Comprehension; Mental Process
T81	ANAT 1138 1149	epidermoide
#76	AnnotatorNotes T81	C0221910; Squamous Epithelial Cells; Cell
T71	PROC 1697 1713	histológicamente
#77	AnnotatorNotes T71	C0344441; Histology Procedure; Laboratory Procedure
A2	Assertion T18 Negated
A3	Population_data T94 Age
A4	Assertion T46 Negated
A5	Assertion T47 Negated
A1	Status T17 History_of
A6	Assertion T53 Contraindicated
A7	Assertion T31 Contraindicated
A8	Assertion T30 Contraindicated
A9	Status T32 History_of
A10	Status T44 History_of
A11	Assertion T15 Negated
#78	AnnotatorNotes T2	C1705187; Safety Study; Research Activity + C3274448; Tolerability Study; Research Activity + C0201734; Pharmacokinetic study; Research Activity 
#79	AnnotatorNotes T48	C0021079; Therapeutic immunosuppression; Therapeutic or Preventive Procedure
#80	AnnotatorNotes T8	C0021079; Therapeutic immunosuppression; Therapeutic or Preventive Procedure
#81	AnnotatorNotes T27	C0851121; Digestive problems; Sign or Symptom 
T86	Quantifier_or_Qualifier 1765 1774	aceptable
A12	Assertion T86 Negated
T87	Neg_cue 1762 1764	no
R1	Negation Arg1:T76 Arg2:T18	
R2	Negation Arg1:T87 Arg2:T86	
T90	Spec_cue 1967 1972	pueda
T99	Observation 1973 2000	dificultar la participación
A13	Assertion T99 Speculated
R3	Speculation Arg1:T90 Arg2:T99	
R4	Negation Arg1:T95 Arg2:T46	
T100	Quantifier_or_Qualifier 2240 2248	eficaces
A14	Assertion T100 Negated
R5	Has_Quantifier_or_Qualifier Arg1:T46 Arg2:T100	
R6	Experiences Arg1:T62 Arg2:T48	
R7	Experiences Arg1:T62 Arg2:T49	
R8	Used_for Arg1:T3 Arg2:T48	
R9	Before Arg1:T4 Arg2:T49	
R10	Used_for Arg1:T49 Arg2:T48	
R11	Used_for Arg1:T4 Arg2:T48	
R12	Experiences Arg1:T62 Arg2:T5	
R13	Location_of Arg1:T50 Arg2:T5	
T101	Quantifier_or_Qualifier 289 296	ESTABLE
R14	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T101	
R15	Experiences Arg1:T62 Arg2:T61	
R16	Overlap Arg1:T48 Arg2:T5	
T102	Quantifier_or_Qualifier 341 348	estable
R17	Location_of Arg1:T7 Arg2:T6	
R18	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T102	
R19	Has_Age Arg1:T63 Arg2:T64	
R20	Used_for Arg1:T9 Arg2:T8	
R21	Used_for Arg1:T10 Arg2:T8	
R22	Experiences Arg1:T65 Arg2:T8	
R23	Before Arg1:T8 Arg2:T11	
R24	Has_Duration_or_Interval Arg1:T11 Arg2:T67	
R25	Experiences Arg1:T65 Arg2:T11	
T103	Observation 614 629	en fase estable
#82	AnnotatorNotes T103	C1282982; Patient's condition stable; Finding
R26	Has_Quantifier_or_Qualifier Arg1:T68 Arg2:T103	
T104	Result_or_Value 693 702	5-15 µg/L
R27	Has_Result_or_Value Arg1:T51 Arg2:T104	
T105	Quantifier_or_Qualifier 719 732	dos ocasiones
R28	Has_Quantifier_or_Qualifier Arg1:T51 Arg2:T105	
R29	Overlap Arg1:T51 Arg2:T72	
T106	PROC 808 817	selección
#83	AnnotatorNotes T106	C0242802; Patient Selection; Research Activity
R30	Experiences Arg1:T68 Arg2:T51	
R31	Overlap Arg1:T51 Arg2:T106	
R32	Experiences Arg1:T73 Arg2:T66	
T107	Observation 975 999	participar en el estudio
#84	AnnotatorNotes T107	C1278516; Patient participation status; Finding
R34	Before Arg1:T14 Arg2:T107	
R35	Overlap Arg1:T66 Arg2:T14	
R36	Experiences Arg1:T74 Arg2:T16	
R37	Experiences Arg1:T74 Arg2:T17	
R38	Has_Duration_or_Interval Arg1:T17 Arg2:T75	
R39	Location_of Arg1:T52 Arg2:T18	
R40	Location_of Arg1:T81 Arg2:T18	
R41	Experiences Arg1:T74 Arg2:T18	
R42	Experiences Arg1:T74 Arg2:T15	
R43	Experiences Arg1:T78 Arg2:T20	
R44	Experiences Arg1:T79 Arg2:T21	
R45	Experiences Arg1:T79 Arg2:T22	
R46	Experiences Arg1:T80 Arg2:T23	
R47	Experiences Arg1:T80 Arg2:T24	
R48	Location_of Arg1:T28 Arg2:T27	
R49	Experiences Arg1:T80 Arg2:T25	
R50	Experiences Arg1:T80 Arg2:T27	
T108	Spec_cue 1400 1406	puedan
T109	CONC 1407 1414	afectar
A15	Assertion T109 Speculated
#85	AnnotatorNotes T109	C0521102; Interferes with; Functional Concept
R51	Speculation Arg1:T108 Arg2:T109	
R52	Experiences Arg1:T80 Arg2:T69	
R53	Experiences Arg1:T80 Arg2:T29	
R54	Used_for Arg1:T29 Arg2:T69	
R55	Used_for Arg1:T31 Arg2:T53	
R56	Used_for Arg1:T30 Arg2:T53	
R58	Overlap Arg1:T32 Arg2:T83	
T110	CONC 1625 1634	inclusión
#86	AnnotatorNotes T110	C1512693; Inclusion; Qualitative Concept
R59	Before Arg1:T32 Arg2:T110	
R60	Has_Duration_or_Interval Arg1:T33 Arg2:T84	
R61	Location_of Arg1:T54 Arg2:T35	
R62	Location_of Arg1:T36 Arg2:T26	
R63	Location_of Arg1:T36 Arg2:T70	
R64	Experiences Arg1:T85 Arg2:T70	
R65	Experiences Arg1:T85 Arg2:T26	
#87	AnnotatorNotes T26	C0858943; Impaired lung function; Finding
T111	Result_or_Value 1820 1827	≥ 3 ULN
R66	Has_Result_or_Value Arg1:T38 Arg2:T111	
R67	Has_Result_or_Value Arg1:T57 Arg2:T111	
R68	Has_Result_or_Value Arg1:T56 Arg2:T111	
R69	Has_Result_or_Value Arg1:T55 Arg2:T111	
R70	Has_Result_or_Value Arg1:T37 Arg2:T111	
T112	Result_or_Value 1848 1857	≥ 2 mg/dl
R71	Has_Result_or_Value Arg1:T59 Arg2:T112	
R72	Location_of Arg1:T40 Arg2:T59	
R74	Experiences Arg1:T88 Arg2:T41	
R75	Experiences Arg1:T88 Arg2:T42	
R76	Experiences Arg1:T88 Arg2:T43	
T113	Observation 2018 2044	participan simultáneamente
T114	Observation 2047 2095	han participado en otro estudio de investigación
T115	Observation 2124 2145	entrada en el estudio
#88	AnnotatorNotes T115	C0422726; Patient entered into trial; Finding 
R80	Before Arg1:T114 Arg2:T115	
R81	Experiences Arg1:T93 Arg2:T45	
R82	Has_Age Arg1:T94 Arg2:T77	
R83	Experiences Arg1:T94 Arg2:T46	
R84	Negation Arg1:T98 Arg2:T47	
T116	Quantifier_or_Qualifier 1332 1338	severa
#89	AnnotatorNotes T116	C1547227; Severe - Severity of Illness Code; Intellectual Product (?)
R85	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T116	
T117	Quantifier_or_Qualifier 1364 1370	activa
#90	AnnotatorNotes T117	C0679217; Active State; Idea or Concept
R86	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T117	
R92	Before Arg1:T43 Arg2:T99	
R93	Before Arg1:T42 Arg2:T99	
R94	Before Arg1:T41 Arg2:T99	
R95	Location_of Arg1:T13 Arg2:T51	
#91	AnnotatorNotes T101	C0205360; Stable status; Qualitative Concept
#92	AnnotatorNotes T102	C0205360; Stable status; Qualitative Concept
#93	AnnotatorNotes T100	C1704419; Effective; Qualitative Concept
T118	Observation 1173 1191	satisfactoriamente
#94	AnnotatorNotes T118	C0581844; Patient's condition satisfactory; Finding (?)
R96	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T118	
T119	Quantifier_or_Qualifier 1565 1576	un episodio
R97	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T119	
R98	Has_Quantifier_or_Qualifier Arg1:T70 Arg2:T86	
R79	Overlap Arg1:T114 Arg2:T92	
R100	Overlap Arg1:T113 Arg2:T92	
A16	Assertion T118 Negated
R99	Negation Arg1:T76 Arg2:T15	
R101	Negation Arg1:T76 Arg2:T118	
T120	Neg_cue 1150 1152	no
T121	Quantifier_or_Qualifier 1153 1164	metastásico
A17	Assertion T121 Negated
R102	Negation Arg1:T120 Arg2:T121	
R103	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T121	
#95	AnnotatorNotes T121	C1522484; metastatic qualifier; Functional Concept | C0036525; Metastatic to; Functional Concept
#96	AnnotatorNotes T86	C1879533; Acceptable; Qualitative Concept
#97	AnnotatorNotes T105	C1948050; Twice (Numerical Qualifier); Quantitative Concept
A18	Experiencer T62 Patient
A19	Experiencer T63 Patient
A20	Experiencer T65 Patient
A21	Status T11 Future
A22	Experiencer T68 Patient
A23	Experiencer T73 Patient
A24	Experiencer T74 Patient
A25	Experiencer T78 Patient
A26	Experiencer T79 Patient
A27	Experiencer T80 Patient
A28	Experiencer T82 Patient
A29	Experiencer T85 Patient
A30	Experiencer T88 Patient
A31	Experiencer T91 Patient
A32	Experiencer T93 Patient
A33	Experiencer T94 Patient
A34	Experiencer T89 Other
